Fisher Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.91B | Buy |
34,522,363
+1,326,378
| +4% | +$71.9M | 0.65% | 46 |
|
|
2025
Q4 | $1.63B | Buy |
33,195,985
+968,370
| +3% | +$45.2M | 0.56% | 47 |
|
|
2025
Q3 | $1.39B | Buy |
32,227,615
+889,210
| +3% | +$34.7M | 0.5% | 58 |
|
|
2025
Q2 | $1.2B | Buy |
31,338,405
+1,306,590
| +4% | +$49.9M | 0.48% | 63 |
|
|
2025
Q1 | $1.16B | Buy |
30,031,815
+11,195,018
| +59% | +$410M | 0.5% | 65 |
|
|
2024
Q4 | $637M | Buy |
18,836,797
+259,867
| +1% | +$9.35M | 0.25% | 83 |
|
|
2024
Q3 | $759M | Buy |
18,576,930
+870,449
| +5% | +$35.6M | 0.31% | 79 |
|
|
2024
Q2 | $682M | Buy |
17,706,481
+2,038,221
| +13% | +$85.7M | 0.3% | 84 |
|
|
2024
Q1 | $672M | Buy |
15,668,260
+631,379
| +4% | +$26M | 0.31% | 85 |
|
|
2023
Q4 | $557M | Buy |
15,036,881
+1,436,488
| +11% | +$51.6M | 0.29% | 88 |
|
|
2023
Q3 | $493M | Sell |
13,600,393
-221,437
| -2% | -$7.86M | 0.28% | 98 |
|
|
2023
Q2 | $493M | Buy |
13,821,830
+547,165
| +4% | +$19.6M | 0.27% | 101 |
|
|
2023
Q1 | $473M | Buy |
13,274,665
+554,079
| +4% | +$19.4M | 0.29% | 104 |
|
|
2022
Q4 | $447M | Buy |
12,720,586
+548,735
| +5% | +$18.3M | 0.3% | 89 |
|
|
2022
Q3 | $358M | Sell |
12,171,851
-3,482,648
| -22% | -$132M | 0.27% | 94 |
|
|
2022
Q2 | $852M | Buy |
15,654,499
+480,732
| +3% | +$26.5M | 0.6% | 53 |
|
|
2022
Q1 | $826M | Buy |
15,173,767
+600,033
| +4% | +$32.6M | 0.49% | 64 |
|
|
2021
Q4 | $803M | Buy |
14,573,734
+309,414
| +2% | +$16.1M | 0.45% | 60 |
|
|
2021
Q3 | $681M | Buy |
14,264,320
+225,927
| +2% | +$11.3M | 0.42% | 65 |
|
|
2021
Q2 | $699M | Buy |
14,038,393
+420,805
| +3% | +$20.2M | 0.44% | 62 |
|
|
2021
Q1 | $608M | Buy |
13,617,588
+396,313
| +3% | +$18M | 0.43% | 65 |
|
|
2020
Q4 | $608M | Buy |
13,221,275
+240,301
| +2% | +$11M | 0.46% | 62 |
|
|
2020
Q3 | $611M | Buy |
12,980,974
+278,436
| +2% | +$14M | 0.53% | 51 |
|
|
2020
Q2 | $648M | Buy |
12,702,538
+270,566
| +2% | +$13.9M | 0.63% | 43 |
|
|
2020
Q1 | $589M | Buy |
12,431,972
+101,603
| +0.8% | +$5.42M | 0.73% | 43 |
|
|
2019
Q4 | $724M | Buy |
12,330,369
+116,299
| +1% | +$6.47M | 0.73% | 43 |
|
|
2019
Q3 | $652M | Buy |
12,214,070
+1,129,894
| +10% | +$58.1M | 0.72% | 43 |
|
|
2019
Q2 | $554M | Sell |
11,084,176
-576,626
| -5% | -$28.9M | 0.61% | 50 |
|
|
2019
Q1 | $609M | Buy |
11,660,802
+378,754
| +3% | +$18.9M | 0.71% | 43 |
|
|
2018
Q4 | $539M | Buy |
11,282,048
+72,986
| +0.7% | +$3.59M | 0.74% | 42 |
|
|
2018
Q3 | $563M | Buy |
11,209,062
+149,764
| +1% | +$7.61M | 0.68% | 44 |
|
|
2018
Q2 | $557M | Buy |
11,059,298
+316,623
| +3% | +$15.9M | 0.72% | 39 |
|
|
2018
Q1 | $525M | Buy |
10,742,675
+518,898
| +5% | +$24.2M | 0.7% | 43 |
|
|
2017
Q4 | $453M | Sell |
10,223,777
-38,824
| -0.4% | -$1.79M | 0.59% | 53 |
|
|
2017
Q3 | $521M | Buy |
10,262,601
+235,093
| +2% | +$11.9M | 0.73% | 45 |
|
|
2017
Q2 | $540M | Buy |
10,027,508
+451,615
| +5% | +$24.1M | 0.82% | 38 |
|
|
2017
Q1 | $505M | Buy |
9,575,893
+128,293
| +1% | +$6.51M | 0.81% | 40 |
|
|
2016
Q4 | $455M | Sell |
9,447,600
-41,338
| -0.4% | -$2.04M | 0.79% | 41 |
|
|
2016
Q3 | $512M | Buy |
9,488,938
+104,238
| +1% | +$5.72M | 0.91% | 32 |
|
|
2016
Q2 | $511M | Buy |
9,384,700
+58,416
| +0.6% | +$3.08M | 0.95% | 35 |
|
|
2016
Q1 | $500M | Buy |
9,326,284
+100,946
| +1% | +$5.03M | 0.95% | 35 |
|
|
2015
Q4 | $465M | Buy |
9,225,338
+2,883
| +0% | +$147K | 0.9% | 41 |
|
|
2015
Q3 | $443M | Sell |
9,222,455
-4,242
| -0% | -$221K | 0.92% | 39 |
|
|
2015
Q2 | $480M | Buy |
9,226,697
+621,033
| +7% | +$35M | 0.93% | 39 |
|
|
2015
Q1 | $496M | Sell |
8,605,664
-6,339
| -0.1% | -$363K | 0.99% | 35 |
|
|
2014
Q4 | $460M | Sell |
8,612,003
-578,872
| -6% | -$32.4M | 0.95% | 37 |
|
|
2014
Q3 | $528M | Buy |
9,190,875
+98,153
| +1% | +$6.02M | 1.13% | 35 |
|
|
2014
Q2 | $608M | Buy |
9,092,722
+121,231
| +1% | +$8.21M | 1.28% | 29 |
|
|
2014
Q1 | $599M | Buy |
8,971,491
+82,764
| +0.9% | +$5.6M | 1.35% | 27 |
|
|
2013
Q4 | $593M | Sell |
8,888,727
-6,538
| -0.1% | -$424K | 1.34% | 27 |
|
|
2013
Q3 | $558M | Sell |
8,895,265
-23,355
| -0.3% | -$1.5M | 1.37% | 29 |
|
|
2013
Q2 | $557M | Buy |
+8,918,620
| New | +$566M | 1.45% | 25 |
|
Other funds holding GSK
JEST
